Systematic reviews in cystic fibrosis

Elborn J.S. , Shale D.J. , Britton J.R. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax 1991; 46: 881–5.

Robson M. , Abbott J. , Webb K. , Dodd M. , Walsworth-Bell J. A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients. Thorax 1992; 47: 684–9.

Anonymous. Dornase alfa for cystic fibrosis. DTB 1995; 33: 15–16.

Cheng K. , Ashby D. , O'Hea U. , Smyth R.L. The epidemiology of randomised controlled trials in cystic fibrosis. Israel J Med Sci 1996; 32(Suppl): S260.

Cochrane A.L. Effectiveness and Efficiency: Random Reflections on Health Services. London: Nuffield Provincial Hospital Trust, 1972.

Bradley F. , Field J. Evidence-based medicine. Lancet 1995; 346: 838–9.

Oxman A.D. , Sackett D.L. , Guyatt G.H. Users' guide to the medical literature I. How to get started. JAMA 1993; 270: 2093–5.

Guyatt G.H. , Rennie D. Users' guide to the medical literature [Editorial]. JAMA 1993; 270: 2096–7.

Mulrow C.D. The medical review article: state of the science. Ann Intern Med 1987; 104: 485–8.

Yusuf S. , Collins R. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomised controlled trials. Eur Heart J 1985; 6: 556–85.

MacMahon S. , Collins R. , Peto R. , Koster R.W. , Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction. JAMA 1988; 260: 1910–16.

Jadad A.R. , Moore R.A. , Carroll D. Assessing the quality of reports of randomised controlled trials: Is blinding necessary? Controlled Clin Trials 1995; 134: 1–12.

Easterbrook P.J. , Berlin J.A. , Gopalan R. , Matthews D.R. Publication bias in clinical research. Lancet 1991; 337: 867–72.

Cheng K. , Ashby D. , O'Hea U. , Smyth R.L. What proportion of randomised controlled trials in cystic fibrosis, published as abstracts achieve full publication? Israel J Med Sci 1996; 32(Suppl): S261.

Chalmers I. , Adams M. , Dickersin K. , Hetherington J. , Tarnow-Mordi W. , Meinert C. A cohort study of summary reports of controlled trials. JAMA 1990; 2631: 1401–5.

Savulescu J. , Chalmers I. , Blunt J. Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability. BMJ 1996; 313: 1390–1393.

Schulz K. , Chalmers I. , Hayes R.J. , Altman D.G. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408–12.

Jadad A. , Moore R.A. , Carroll D. , Jenkinson C. , Reynolds J.M. , Gavaghan D.J. Assessing the quality of reports of randomised controlled trials: is blinding necessary? Controlled Clin Trials 1996; 17: 1–12.

Egger M. , Smith G.D. Misleading meta-analysis. BMJ 1995; 310: 752–4.

Villar J. , Carroli G. , Belizan J.M. Predictive ability of meta-analyses of randomised controlled trials. Lancet 1995; 345: 772–6.

Cappelleri J.C. , Ioannidis J.P.A. , Schmid C.H. , de Ferranti S.D. , Aubert M. Large trials versus meta-analysis of smaller trials. How do their results compare? JAMA 1996; 276: 1332–8.

LeLorier J. , Gregorie G. , Benaddad A. , Lapierre J. , Derderian F. Discrepancies between meta-analyses and subsequent large randomised controlled trials. N Engl J Med 1997; 337: 536–4–2.

Naylor C.D. Meta-analysis and the meta-epidemiology of clinical research [Editorial]. BMJ 1997; 315: 617–19.

Naylor C.D. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet 1995; 345: 840–2.

Chalmers I. , Enkin M. , Keirse M.J.N.C. , eds. Effective Care in Pregnancy and Childbirth. Oxford: Oxford University Press, 1989.

The Cochrane Collaboration, The Cochrane Library [database on disk and CDROM]. Issue 3. Oxford: Update Software, 1997.

Cheng K. , Ashby D. , Smyth R. Ursodeoxycholic acid in cystic fibrosis-related liver disease: a systematic review. J R Soc Med 1997; 90: 6–12.

Cheng K. , Smyth R. , Ashby D. Ursodeoxycholic acid in cystic fibrosis-related liver disease. In: Smyth R.L. , Walters S. , Ryan G. , eds. Cystic Fibrosis Module of The Cochrane Database of Systemtic Reviews (updated 02 June 1997). The Cochrane Library [database on disk and CDROM], Issue 3. Oxford: Update Software, 1997 [updated quarterly].

Cheng K. , Smyth R.L. , Ashby D. Oral steroiods in cystic fibrosis. In: Smyth R.L. , Ryan G. , Walters S. , eds. Cystic fibrosis Module of The Cochrane Database of Systematic Reviews, (updated 01 September 1997). The Cochrane Library [database on disk and CDMROM]. Issue 4. Oxford: Update Software; 1997 [updated quarterly].

Smyth R.L. , Walters S. Oral calorie supplements in cystic fibrosis. In: Smyth R.L. , Walters S. , eds. Cystic Fibrosis Module of The Cochrane Database of Systematic Reviews. The Cochrane Library [database on disk and CDROM], Issue 1. Oxford: Update Software; 1998 [updated quarterly].